logo
logo

DNAnexus and Galatea Bio Collaborate to Enhance Precision Medicine for Underserved Populations

Aug 14, 2024•11 months ago

Contract Type

partnership

Miami LakesHealth Care

Description

DNAnexus and Galatea Bio have announced a strategic collaboration to enhance biomedical research and precision medicine, particularly for Latin American populations and other underserved groups. The collaboration aims to increase access to advanced genetic tools that can improve diagnostic testing, accelerate drug discovery, and optimize health outcomes.

Company Information

Company

Galatea Bio

Location

Miami Lakes, Florida, United States

About

Galatea Bio is building the largest longitudinal cohort in the Americas to power precision health at scale for all. Our goal is to improve diagnostic testing and accelerate drug discovery in diverse underserved populations. We are focused on Latin America and our diaspora populations throughout the world including founder populations in the Americas, those who identify as Hispanic/Latino, Black or African American, Asian American, American Indian/Alaska Native, First Nations, and Native Hawaiian/Pacific Islander as well as people who self identify as belonging to two or more of these groups.

Agreement Insights

Based on industry data
Strategic partnership established
Partnership agreements typically involve technology integration and joint go-to-market strategies
Contract momentum indicator
Companies with recent agreements are 2.3x more likely to make additional purchases within 6 months

Related People